S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 481 to 539 of 539

Issue Date	Title / Author(s) / Citation	File
2020-01	Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study Yoo, Shin Hye; Kang, Seo Young; Cheon, Gi Jeong; Oh, Do-Youn; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.61 No.1, pp.33-39	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI
2020-01	The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Medicine, Vol.9 No.1, pp.43-51	DOI
2020-01	The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Medicine, Vol.9 No.1, pp.43-51	DOI
2020-02	Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma Kelly, Ronan J.; Lee, Jeeyun; Bang, Yung-Jue; Almhanna, Khaldoun; Blum-Murphy, Mariela; Catenacci, Daniel V. T.; Hyun Cheol Chung; Wainberg, Zev A.; Gibson, Michael K.; Lee, Keun-Wook; Bendell, Johanna C.; Denlinger, Crystal S.; Chee, Cheng Ean; Omori, Takeshi; Leidner, Rom; Lenz, Heinz-Josef; Chao, Yee; Rebelatto, Marlon C.; Brohawn, Philip Z.; He, Peng; McDevitt, Jennifer; Sheth, Siddharth; Englert, Judson M.; Ku, Geoffrey Y. Clinical Cancer Research, Vol.26 No.4, pp.846-854	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, Yung-Jue; Li, Chung-Pin; Lee, Kyung-Hun; Chiu, Chang-Fang; Park, Joon Oh; Shan, Yan-Shen; Kim, Jun Suk; Chen, Jen-Shi; Shim, Hyun-Jeong; Rau, Kun-Ming; Choi, Hye Jin; Oh, Do-Youn; Belanger, Bruce; Chen, Li-Tzong Cancer Science, Vol.111 No.2, pp.513-527	view file DOI
2020-02	Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study Kato, Hidenori; de Souza, Paul; Kim, Sang-We; Lickliter, Jason D.; Naito, Yoichi; Park, Keunchil; Kumar, Sanjeev; Mugundu, Ganesh M.; Bang, Yung-Jue Targeted Oncology, Vol.15 No.1, pp.75-84	view file DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2020-06	Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun-Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Saito, Kaku; Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro; Yamaguchi, Kensei New England Journal of Medicine, Vol.382 No.25, pp.2419-2430	DOI
2020-07	Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma Catenacci, Daniel V. T.; Rasco, Drew; Lee, Jeeyun; Rha, Sun Young; Lee, Keun-Wook; Bang, Yung Jue; Bendell, Johanna; Enzinger, Peter; Marina, Neyssa; Xiang, Hong; Deng, Wei; Powers, Janine; Wainberg, Zev A. Journal of Clinical Oncology, Vol.38 No.21, pp.2418-2426	DOI
2020-07	Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer Nam, Ah-Rong; Jin, Mie-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.52 No.3, pp.945-956	view file DOI
2020-07	Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer Kang, Yoon-Koo; Bang, Yung-Jue; Kondo, Shunsuke; Chung, Hyun Cheol; Muro, Kei; Dussault, Isabelle; Helwig, Christoph; Osada, Motonobu; Doi, Toshihiko Clinical Cancer Research, Vol.26 No.13, pp.3202-3210	DOI
2020-08	S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu The Lancet Oncology, Vol.21 No.8, pp.1045-1056	DOI
2020-08	Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial Catenacci, Daniel V. T.; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E.; Lee, Keun-Wook; Ng, Matthew C. H.; Enzinger, Peter C.; Park, Se Hoon; Gold, Philip J.; Lacy, Jill; Hochster, Howard S.; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A.; Kelly, Ronan J.; Juergens, Rosalyn A.; Kim, Jong Gwang; Bendell, Johanna C.; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A. Craig; Knutson, Keith L.; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L.; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K.; Rosales, Minori Koshiji; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.8, pp.1066-1076	DOI
2020-09	Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ) Bang, Yung-Jue; Golan, Talia; Dahan, Laetitia; Fu, Siqing; Moreno, Victor; Park, Keunchil; Geva, Ravit; De Braud, Filippo; Wainberg, Zev A.; Reck, Martin; Goff, Laura; Laing, Naomi; Mi, Gu; Oliveira, Joana M.; Wasserstrom, Heather; Lin, Chia-Chi European Journal of Cancer, Vol.137, pp.272-284	DOI
2020-09	KrAsG12C inhibition with Sotorasib in Advanced Solid Tumors Hong, David S.; Fakih, Marwan G.; Strickler, John H.; Desai, Jayesh; Durm, Gregory A.; Shapiro, Geoffrey I.; Falchook, Gerald S.; Price, Timothy J.; Sacher, Adrian; Denlinger, Crystal S.; Bang, Yung-Jue; Dy, Grace K.; Krauss, John C.; Kuboki, Yasutoshi; Kuo, James C.; Coveler, Andrew L.; Park, Keunchil; Kim, Tae Won; Barlesi, Fabrice; Munster, Pamela N.; Ramalingam, Suresh S.; Burns, Timothy F.; Meric-Bernstam, Funda; Henary, Haby; Ngang, Jude; Ngarmchamnanrith, Gataree; Kim, June; Houk, Brett E.; Canon, Jude; Lipford, J. Russell; Friberg, Gregory; Lito, Piro; Govindan, Ramaswamy; Li, Bob T. New England Journal of Medicine, Vol.383 No.13, pp.1207-1217	DOI
2020-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI
2020-10	Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study Marabelle, Aurelien; Fakih, Marwan; Lopez, Juanita; Shah, Manisha; Shapira-Frommer, Ronnie; Nakagawa, Kazuhiko; Chung, Hyun Cheol; Kindler, Hedy L.; Lopez-Martin, Jose A.; Miller, Wilson H., Jr.; Italiano, Antoine; Kao, Steven; Piha-Paul, Sarina A.; Delord, Jean-Pierre; McWilliams, Robert R.; Fabrizio, David A.; Aurora-Garg, Deepti; Xu, Lei; Jin, Fan; Norwood, Kevin; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.10, pp.1353-1365	DOI
2020-10	Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christian; Villanueva, Luis; Goekkurt, Eray; Satake, Hironaga; Enzinger, Peter; Alsina, Maria; Benson, Al; Chao, Joseph; Ko, Andrew H.; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, S. Peter; Tabernero, Josep JAMA oncology, Vol.6 No.10, pp.1571-1580	DOI
2020-10	Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer Kim, Jin Won; Cho, Sung-Yup; Chae, Jeesoo; Kim, Ji-Won; Kim, Tae-Yong; Lee, Keun-Wook; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.52 No.4, pp.1178-1187	DOI
2021-01	Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor Hong, D. S.; Bang, Yung-Jue; Barlesi, F.; Durm, G.; Falchook, G.; Govindan, R.; Dy, G.; Park, K.; Strickler, J.; Burns, T.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T. Journal of Thoracic Oncology, Vol.16 No.1, pp.S28-S29	DOI
2021-02	First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 Chung, Hyun Cheol; Bang, Yung-Jue; S Fuchs, Charles; Qin, Shu-Kui; Satoh, Taroh; Shitara, Kohei; Tabernero, Josep; van Cutsem, Eric; Alsina, Maria; Cao, Zhu Alexander; Lu, Jia; Bhagia, Pooja; Shih, Chie-Schin; Janjigian, Yelena Y. Future Oncology, Vol.17 No.5, pp.491-501	DOI
2021-03	KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma Tabernero, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Janjigian, Yelena Yuriy; Bhagia, Pooja; Li, Kan; Adelberg, David; Qin, Shu Kui Future Oncology, Vol.17 No.22, pp.2847-2855	DOI
2021-03	Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung-Jue; Lin, Chia-Chi; Su, Wu-Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna Clinical Cancer Research, Vol.27 No.5, pp.1267-1277	DOI
2021-03	Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100 Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu; Ozguroglu, Mustafa; Ryu, Min-Hee; Muntean, Alina S.; Lonardi, Sara; Nechaeva, Marina; Bragagnoli, Arinilda C.; Coskun, Hasan S.; Cubillo Gracian, Antonio; Takano, Toshimi; Wong, Rachel; Safran, Howard; Vaccaro, Gina M.; Wainberg, Zev A.; Silver, Matthew R.; Xiong, Huiling; Hong, Janet; Taieb, Julien; Bang, Yung-Jue Journal of Clinical Oncology, Vol.39 No.9, pp.966-977	DOI
2021-04	Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10 Wainberg, Zev A.; Fuchs, Charles S.; Tabernero, Josep; Shitara, Kohei; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; Chung, Hyun Cheol; Yamaguchi, Kensei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrido, Marcelo; Kher, Uma; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Chao, Joseph Clinical Cancer Research, Vol.27 No.7, pp.1923-1931	DOI
2021-04	Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody Harding, James J.; Moreno, Victor; Bang, Yung-Jue; Hong, Min Hee; Patnaik, Amita; Trigo, Jose; Szpurka, Anna M.; Yamamoto, Noboru; Doi, Toshihiko; Fu, Siqing; Calderon, Boris; de Mendizabal, Nieves Velez; Calvo, Emiliano; Yu, Danni; Gandhi, Leena; Liu, Zhuqing Tina; Galvao, Violeta Regnier; Leow, Ching Ching; de Miguel, Maria J. Clinical Cancer Research, Vol.27 No.8, pp.2168-2178	DOI
2021-05	A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors Chung, Tae Kyu; Lee, Hyun A.; Park, Sang-In; Oh, Do-Youn; Lee, Keun-Wook; Kim, Jin Won; Kim, Jee Hyun; Woo, Ahmi; Lee, Su Jin; Bang, Yung-Jue; Lee, Howard Clinical and Translational Science, Vol.14 No.3, pp.990-1001	DOI
2021-06	Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao, Joseph; Fuchs, Charles S.; Shitara, Kohei; Tabernero, Josep; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; De Vita, Ferdinando; Landers, Gregory; Yen, Chia-Jui; Chau, Ian; Elme, Anneli; Lee, Jeeyun; Ozguroglu, Mustafa; Catenacci, Daniel; Yoon, Harry H.; Chen, Erluo; Adelberg, David; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Wainberg, Zev A. JAMA oncology, Vol.7 No.6, pp.895-902	DOI
2021-08	Quality of life with first-line pembrolizumab for PD-L1epositive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study Van Cutsem, E.; Valderrama, A.; Bang, Y. -J.; Fuchs, C. S.; Shitara, K.; Janjigian, Y. Y.; Qin, S.; Larson, T. G.; Shankaran, V.; Stein, S.; Norquist, J. M.; Kher, U.; Shah, S.; Alsina, M. Esmo Open, Vol.6 No.4, p. 100189	DOI
2021-09	Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma Shitara, K.; Ozguroglu, M.; Bang, Y-J; Di Bartolomeo, M.; Mandala, M.; Ryu, M-H; Caglevic, C.; Chung, H. C.; Muro, K.; Van Cutsem, E.; Kobie, J.; Cristescu, R.; Aurora-Garg, D.; Lu, J.; Shih, C-S; Adelberg, D.; Cao, Z. A.; Fuchs, C. S. Annals of Oncology, Vol.32 No.9, pp.1127-1136	DOI
2021-09	SPOTLIGHT: Phase 3 study of Zolbetuximab+mFOLFOX6 versus placebo+mFOLFOX6 in first-line claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ) Lordick, F.; Shitara, K.; Al-Batran, S. -E; Bang, Y. -J; Catenacci, D.; Enzinger, P.; Ilson, D.; Kim, S.; Shah, M. A.; Van Cutsem, E.; Xu, R. -H; Arozullah, A.; Park, J. W.; Ajani, J. Oncology Research and Treatment, Vol.44, pp.218-218
2021-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI
2021-11	EVORPACEPT (ALX148), A CD47 MYELOID CHECKPOINT INHIBITOR, IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) AND WITH GASTRIC/GASTROESOPHAGEAL CANCER (GC); ASPEN-01 Lee, Keun-Wook; Chung, Hyun; Kim, Tae Min; Lakhani, Nehal; Messersmith, Wells; Santana-Davila, Rafael; Kim, Won Seog; LoRusso, Patricia; Bang, Yung-Jue; Chow, Laura; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Forgie, Alison; Wan, Hong; Pons, Jaume; Randolph, Sophia; Gainor, Justin Journal for ImmunoTherapy of Cancer, Vol.9, pp.A530-A530	DOI
2021-11	Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 Van Cutsem, Eric; Amonkar, Mayur; Fuchs, Charles S.; Alsina, Maria; Ozguroglu, Mustafa; Bang, Yung-Jue; Chung, Hyun Cheol; Muro, Kei; Goekkurt, Eray; Benson, Al B., III; Sun, Weijing; Wainberg, Zev A.; Norquist, Josephine M.; Chen, Xinqun; Shih, Chie-Schin; Shitara, Kohei Gastric Cancer, Vol.24 No.6, pp.1330-1340	DOI
2021-11	Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors Takahashi, Shunji; Karayama, Masato; Takahashi, Masato; Watanabe, Junichiro; Minami, Hironobu; Yamamoto, Noboru; Kinoshita, Ichiro; Lin, Chia-Chi; Im, Young-Hyuck; Achiwa, Issei; Kamiyama, Emi; Okuda, Yasuyuki; Lee, Caleb; Bang, Yung-Jue Clinical Cancer Research, Vol.27 No.21, pp.5771-5780	DOI
2021-12	Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study Lakhani, Nehal J.; Chow, Laura Q. M.; Gainor, Justin F.; LoRusso, Patricia; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Bang, Yung-Jue; Hodi, Frank Stephen; Kim, Won Seog; Santana-Davila, Rafael; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Kuo, Tracy C.; Wan, Hong, I; Pons, Jaume; Randolph, Sophia S.; Messersmith, Wells A. The Lancet Oncology, Vol.22 No.12, pp.1740-1751
2021-12	Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L. Investigational New Drugs, Vol.39 No.6, pp.1587-1597	DOI
2021-12	Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors Hollebecque, Antoine; Chung, Hyun C.; de Miguel, Maria J.; Italiano, Antoine; Machiels, Jean-Pascal; Lin, Chia-Chi; Dhani, Neesha C.; Peeters, Marc; Moreno, Victor; Su, Wu-Chou; Chow, Kay Hoong; Galvao, Violeta R.; Carlsen, Michelle; Yu, Danni; Szpurka, Anna M.; Zhao, Yumin; Schmidt, Shelly L.; Gandhi, Leena; Xu, Xiaojian; Bang, Yung-Jue Clinical Cancer Research, Vol.27 No.23, pp.6393-6404	DOI
2022-01	Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Fuchs, Charles S.; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei Gastric Cancer, Vol.25 No.1, pp.197-206	DOI
2022-06	Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer Park, Sehhoon; Ock, Chan-Young; Kim, Hyojin; Pereira, Sergio; Park, Seonwook; Ma, Minuk; Choi, Sangjoon; Kim, Seokhwi; Shin, Seunghwan; Aum, Brian Jaehong; Paeng, Kyunghyun; Yoo, Donggeun; Cha, Hongui; Park, Sunyoung; Suh, Koung Jin; Jung, Hyun Ae; Kim, Se Hyun; Kim, Yu Jung; Sun, Jong-Mu; Chung, Jin-Haeng; Ahn, Jin Seok; Ahn, Myung-Ju; Lee, Jong Seok; Park, Keunchil; Song, Sang Yong; Bang, Yung-Jue; Choi, Yoon-La; Mok, Tony S.; Lee, Se-Hoon Journal of Clinical Oncology, Vol.40 No.17, pp.1916-+	DOI
2022-08	Deconvolution of adult T-cell leukemia/lymphoma with single-cell RNA-seq using frozen archived skin tissue reveals new subset of cancer-associated fibroblast Kim, H.; Joo, E.; Bae, J.; Park, J.; Bang, Yung-Jue; Park, C.; Gulati, N.; Park, W. Journal of Investigative Dermatology, Vol.142 No.8, pp.S16-S16	DOI
2022-08	First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors Kim, Tae Won; Burris, Howard A.; Luken, Maria J. de Miguel; Pishvaian, Michael J.; Bang, Yung-Jue; Gordon, Michael; Awada, Ahmad; Camidge, D. Ross; Hodi, F. Stephen; McArthur, Grant A.; Miller, Wilson H., Jr.; Cervantes, Andres; Chow, Laura Q.; Lesokhin, Alexander M.; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang-Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian L. Clinical Cancer Research, Vol.28 No.16, pp.3452-3463	DOI
2022-09	Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel +/- Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Shah, Manish A.; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C.; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L.; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M.; Xu, Bo; Li, Wei; Li, Chiang J.; Borodyansky, Laura; Van Cutsem, Eric Clinical Cancer Research, Vol.28 No.17, pp.3686-3694	DOI
2023-02	INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M.; Martin, Andrew J.; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J.; Tebbutt, Niall C.; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David BMC Cancer, Vol.23 No.1, p. 12885	DOI
2023-02	Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial Yamaguchi, Kensei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Shimoyama, Tatsu; Lee, Keun-Wook; Saito, Kaku; Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro; Shitara, Kohei Journal of Clinical Oncology, Vol.41 No.4, pp.816-825	DOI
2023-04	Tumor-agnostic efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: ROAR basket study Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H.; Zielinski, Christoph C.; Redhu, Suman; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue Cancer Research, Vol.83 No.8	DOI
2023-05	Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Shah, Manish A; Van Cutsem, Eric; Xu, Rui-Hua; Aprile, Giuseppe; Xu, Jianming; Chao, Joseph; Pazo-Cid, Roberto; Kang, Yoon-Koo; Yang, Jianning; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Park, Jung Wook; Oh, Mok; Ajani, Jaffer A The Lancet, Vol.401 No.10389, pp.1655-1668	DOI
2023-05	Longitudinal integrated spatial transcriptomic profiling and single-cell RNA sequencing analysis of primary extra-mammary Paget's disease Lee, Y.; Jang, J.; Park, H.; Min, K.; Young, J. N.; Poplausky, D.; Gulati, N.; Nguyen-Phuong, T.; Lee, J.; Nam, H.; Bang, Yung-Jue; Kim, H.; Kim, J. Journal of Investigative Dermatology, Vol.143 No.5, pp.S54-S54
2023-05	Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; de Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H. M.; Zielinski, Christoph C.; Redhu, Suman; Boran, Aislyn; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue Nature Medicine, Vol.29 No.5, pp.1103-1112	DOI
2023-05	High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-homing property Lee, B. H.; Bang, Yung-Jue; Lim, S.; Kang, S.; Kim, S.; Kim-Schulze, S.; Park, C.; Kim, H.; Kim, T. Journal of Investigative Dermatology, Vol.143 No.5, pp.S9-S9	DOI
2023-06	Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results Ciardiello, Fortunato; Bang, Yung-Jue; Cervantes, Andres; Dvorkin, Mikhail; Lopez, Charles D.; Metges, Jean-Philippe; Sanchez Ruiz, Antonio; Calvo, Mariona; Strickland, Andrew H.; Kannourakis, George; Muro, Kei; Kawakami, Hisato; Wei, Jia; Borg, Christophe; Zhu, Zhaoyin; Gupta, Neal; Pelham, Robert J.; Shen, Lin Cancer Medicine, Vol.12 No.12, pp.1-10	DOI
2023-08	Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial Shah, Manish A.; Shitara, Kohei; Ajani, Jaffer A.; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Plazas, Javier Gallego; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua Nature Medicine, Vol.29 No.8, pp.2133-2141	DOI
2023-08	Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens Tabernero, Josep; Bedard, Philippe L.; Bang, Yung-Jue; Vieito, Maria; Ryu, Min-Hee; Fagniez, Nathalie; Chadjaa, Mustapha; Soufflet, Christine; Masson, Nina; Gazzah, Anas Cancer Research Communications, Vol.3 No.8, pp.1662-1671	DOI
2023-10	ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma Klempner, Samuel J.; Lee, Keun-Wook; Shitara, Kohei; Metges, Jean-Phillippe; Lonardi, Sara; Ilson, David H.; Fazio, Nicola; Kim, Tae Yong; Bai, Li-Yuan; Moran, Diarmuid; Yang, Jianning; Arozullah, Ahsan; Park, Jung Wook; Raizer, Jeffrey J.; Bang, Yung-Jue; Shah, Manish A. Clinical Cancer Research, Vol.29 No.19, pp.3882-3891	DOI
2024-02	Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types Shen, Jeanne; Choi, Yoon-La; Lee, Taebum; Kim, Hyojin; Chae, Young Kwang; Dulken, Ben W.; Bogdan, Stephanie; Huang, Maggie; Fisher, George A.; Park, Sehhoon; Lee, Se-Hoon; Hwang, Jun-Eul; Chung, Jin-Haeng; Kim, Leeseul; Song, Heon; Pereira, Sergio; Shin, Seunghwan; Lim, Yoojoo; Ahn, Chang Ho; Kim, Seulki; Oum, Chiyoon; Kim, Sukjun; Park, Gahee; Song, Sanghoon; Jung, Wonkyung; Kim, Seokhwi; Bang, Yung-Jue; Mok, Tony S. K.; Ali, Siraj M.; Ock, Chan-Young Journal for ImmunoTherapy of Cancer, Vol.12 No.2, p. 008339	DOI
2024-02	Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study Shitara, Kohei; Rha, Sun Young; Wyrwicz, Lucjan S; Oshima, Takashi; Karaseva, Nina; Osipov, Mikhail; Yasui, Hisateru; Yabusaki, Hiroshi; Afanasyev, Sergey; Park, Young-Kyu; Al-Batran, Salah-Eddin; Yoshikawa, Takaki; Yanez, Patricio; Dib Bartolomeo, Maria; Lonardi, Sara; Tabernero, Josep; Van Cutsem, Eric; Janjigian, Yelena Y; Oh, Do-Youn; Xu, Jianming; Fang, Xiao; Shih, Chie-Schin; Bhagia, Pooja; Bang, Yung-Jue The Lancet Oncology, Vol.25 No.2, pp.212-224	DOI
2024-04	Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies Takahashi, Shunji; Bando, Hideaki; Kinoshita, Ichiro; Modi, Shanu; Tsurutani, Junji; Bang, Yung-Jue; Sato, Yuta; Nakatani, Shunsuke; Lee, Caleb; Sugihara, Masahiro; Okuda, Yasuyuki; Iwata, Hiroji Japanese Journal of Clinical Oncology, Vol.54 No.4, pp.434-443	DOI

1 5 6 7 8 9